Thanks, Bioman. It's the reason I'm excited about the future of the company, especially in 2009. It's not based on hype, or pumping, or any type of dreampt up prospects. It's deeply rooted in data and facts.
If Genasense gets approved for the treatment of CLL, that's just an added bonus for me. My eyes are on the prize, the Agenda Trial results and Tesetaxel partnerships.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.